SS Innovations International (SSII) EBITDA Margin (2022 - 2026)
SS Innovations International's (SSII) quarterly EBITDA Margin came in at 46.24% in Q1 2026, up 6427.0% year-on-year from 0.71% in Q1 2025, and down 110.72% quarter-over-quarter from 21.94% in Q4 2025.
SS Innovations International (SSII) EBITDA Margin (2022 - 2026) Analysis & Trends
SS Innovations International has disclosed EBITDA Margin across 5 years of filings, most recently posting 46.24% for Q1 2026.
- EBITDA Margin for Q1 2026 came in at 46.24%, up 6427.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 26.56% (up 4325.0% YoY), and the FY2025 annual result was 31.54%, up 6389.0% from the prior year.
- EBITDA Margin came in at 46.24% for Q1 2026 at SS Innovations International, down from 21.94% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 3.53% in Q2 2025 to a low of 854.9% in Q4 2023.
- The 5-year median for EBITDA Margin is 92.11% (2024), against an average of 164.1%.
- Across the five-year window, EBITDA Margin plunged 76045 bps in 2023 and soared 82616 bps in 2024, its largest moves.
- SS Innovations International's EBITDA Margin stood at 94.45% in 2022, then plunged by 805 bps to 854.9% in 2023, then surged by 97 bps to 28.74% in 2024, then advanced by 24 bps to 21.94% in 2025, then sank by 111 bps to 46.24% in 2026.
- The last three EBITDA Margin figures came in at 46.24% (Q1 2026), 21.94% (Q4 2025), and 32.74% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -46.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46.24% |
| Dec 31, 2025 | -21.94% |
| Sep 30, 2025 | -32.74% |
| Jun 30, 2025 | -3.53% |
| Mar 31, 2025 | -110.51% |
| Dec 31, 2024 | -28.74% |
| Sep 30, 2024 | -75.38% |
| Jun 30, 2024 | -92.11% |
| Mar 31, 2024 | -272.50% |
| Dec 31, 2023 | -854.90% |
| Sep 30, 2023 | -92.95% |
| Jun 30, 2023 | -293.06% |
| Mar 31, 2023 | -366.73% |
| Dec 31, 2022 | -94.45% |
| Sep 30, 2022 | -75.69% |